Trademark: HYBRID CONCEPTS INTERNATIONAL 2295928
Word
HYBRID CONCEPTS INTERNATIONAL
Device Descrption:
LTRS O ARE PART OF MOLECULAR-DIAGRAM
ID
2295928
Trademark Type
Figurative
Status
Protected: Registered/protected
Application Date
06 June 2022
Registration Date
06 June 2022
Renewal Date
06 June 2032
Owner(s)
Service
Adams Pluck
Goods and Services:
Class 35:
Assistance, advisory services and consultancy with regard to business planning; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; business consulting services; business consulting services in the field of potential medical cures including cell and gene therapies; business consultation in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, chemistry, manufacturing and controls, and quality assurance/quality control; business consulting services, namely, providing assistance in development of business strategies and creative ideation; business management consulting and advisory services; business support services, namely, business consulting to freelancers, start-ups, existing businesses and non-profit organizations; consultancy and advisory services in the field of business strategy; consulting services in the field of medical product approval for commercial purposes; international business consulting services relating to USA and outside of USA product, clinical and commercial development of investigational or approved medical products; new business venture development and formation consulting services; promoting the exchange of information and resources within the scientific research communities to achieve advances in the field of 21st century transformational science; providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; providing independent review of clinical trials for business purposes; promoting technical and scientific investigation, research and experimentation in the field of scientific discovery through support of educational institutions and scientific organizations.
Assistance, advisory services and consultancy with regard to business planning; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; business consulting services; business consulting services in the field of potential medical cures including cell and gene therapies; business consultation in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, chemistry, manufacturing and controls, and quality assurance/quality control; business consulting services, namely, providing assistance in development of business strategies and creative ideation; business management consulting and advisory services; business support services, namely, business consulting to freelancers, start-ups, existing businesses and non-profit organizations; consultancy and advisory services in the field of business strategy; consulting services in the field of medical product approval for commercial purposes; international business consulting services relating to USA and outside of USA product, clinical and commercial development of investigational or approved medical products; new business venture development and formation consulting services; promoting the exchange of information and resources within the scientific research communities to achieve advances in the field of 21st century transformational science; providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; providing independent review of clinical trials for business purposes; promoting technical and scientific investigation, research and experimentation in the field of scientific discovery through support of educational institutions and scientific organizations.
Class 36:
Financial consulting services, namely, advising others regarding intellectual property investments; investment consultation in the fields of product, technical, regulatory, preclinical, clinical, and commercial diligence for innovative potential or investigational medical products.
Financial consulting services, namely, advising others regarding intellectual property investments; investment consultation in the fields of product, technical, regulatory, preclinical, clinical, and commercial diligence for innovative potential or investigational medical products.
Class 42:
Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; medical and scientific research information in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, manufacturing/CMC and quality assurance/quality control; providing information about medical and scientific research; providing information on the subject of scientific research in the field of biochemistry and biotechnology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; scientific and technological services, namely, scientific research in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; scientific research consulting in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; scientific research and development; technological planning and consulting services in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; testing, inspection, research, or development of pharmaceutical preparations for gene therapy; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific consulting and research services relating to foods and dietary supplements; scientific research consulting in the field of cosmetics.
Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; medical and scientific research information in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, manufacturing/CMC and quality assurance/quality control; providing information about medical and scientific research; providing information on the subject of scientific research in the field of biochemistry and biotechnology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; scientific and technological services, namely, scientific research in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; scientific research consulting in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; scientific research and development; technological planning and consulting services in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; testing, inspection, research, or development of pharmaceutical preparations for gene therapy; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific consulting and research services relating to foods and dietary supplements; scientific research consulting in the field of cosmetics.